Emergent Biosolutions EBS Gross margin

Gross margin at other companies

SIGA TechnologiesSIGA

54.4%-22.6pp

AMP

Amphastar PharmaceuticalsAMPH

47.7%-2.2pp

Amneal Pharmaceuticals, Inc.AMRX

39.3%+1.7pp

Lifecore Biomedical, Inc.LFCR

31.3%-1.4pp

Cumberland PharmaceuticalsCPIX

77.2%-7.1pp

CorMedixCRMD

91.9%-3.5pp

FAQ

What is Emergent Biosolutions's gross margin?

Emergent Biosolutions (EBS) reported gross margin of 55.9% in Q2 2026.

How has Emergent Biosolutions's gross margin changed year-over-year?

Emergent Biosolutions's gross margin increased by 4.4% year-over-year, from 53.5% to 55.9%.

What is the long-term trend for Emergent Biosolutions's gross margin?

Over 4 years (2020 to 2025), Emergent Biosolutions's gross margin has grown at a -4.3% compound annual growth rate (CAGR), from 66.9% to 56.1%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.